Investor Presentation First Nine Months of 2022

127 Investor presentation First nine months of 2022 GLP-1 market share and market growth in Rest of World 110% 90% 70% 50% GLP-1 market growth and Novo Nordisk market share DKK billion 160% 98% 116% 120% 70% 5 80% 62% GLP-1 market size and growth -62% 3 0 Rest of World 8 0 69.6% 40% ~116% 30% 52.2% 10% 0% Aug NN market share Aug 2019 NN share of growth 2022 Aug 2021 Novo Nordisk Eli Lilly Others Aug 2022 Market growth (right axis) Novo Nordisk Competitors NN growth (right axis) Source: IQVIA, Aug 2022, Value, MAT; NN: Novo Nordisk

View entire presentation